Skip to main content

Table 2 Sociodemographic and clinical data of patients from France, US, China and UK

From: Development of the SPUR tool: a profiling instrument for patient treatment behavior

 

US (n = 15)

France (n = 15)

China (n = 30)

UK (n = 15)

Condition (n)

    

 Type 2 diabetes

5

4

10

15

 COPD

0

0

10

0

 Multiple sclerosis

5

6

0

0

 Breast cancer with hormone therapy

5

5

10

0

Gender (n)

    

 Male/female

5/10

4/11

15/15

5/10

Age (years)

    

 Median (min–max)

51 (35–71)

58 (38–77)

54 (32–63)

55 (30–80)

Educational level (n)

    

 Some high school

0

1

1

2

 High school

4

3

13

3

 Bachelor’s degree

2

3

12

6

 Post-graduate degree

6

8

3

4

 Other

3

0

0

0

Employment status (n)

    

 Full-time

2

5

7

5

 Part-time

3

1

7

1

 Retired

2

7

13

8

 Unemployed

7

2

3

1

  1. COPD chronic obstructive pulmonary disease